Use of LCAT for treating anemia and red blood cell dysfunction

Details for Australian Patent Application No. 2010259875 (hide)

Owner AlphaCore Pharma LLC

Inventors Auerbach, Bruce; Krause, Brian; Homan, Reynold

Agent A J Park

Pub. Number AU-A-2010259875

PCT Pub. Number WO2010/144904

Priority 61/241,223 10.09.09 US; 61/186,668 12.06.09 US

Filing date 14 June 2010

Wipo publication date 16 December 2010

International Classifications

A61K 38/45 (2006.01) Medicinal preparations containing peptides

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

G01N 33/00 (2006.01) Investigating or analysing materials by specific methods not covered by groups

Event Publications

15 December 2011 PCT application entered the National Phase

  PCT publication WO2010/144904 Priority application(s): WO2010/144904

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010259881-Face gear differentials incorporating a torque ring

2010259873-Carpet tiles and methods of producing carpet tiles with diversity of color and texture